MINNEAPOLIS, Oct. 27, 2016 -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the company is scheduled to present at the Stifel 2016 Healthcare Conference in New York City on Wednesday, November 16th at 11:00am (EST). The company will also present at the Canaccord Genuity Medical Technologies & Diagnostics Forum in New York City on Thursday, November 17th at 11:00am (EST).
Howard Root, Chief Executive Officer of Vascular Solutions, will deliver the company’s presentations. To hear the live audio webcast of the Vascular Solutions’ presentation, go to the investor relations page of the company’s web site www.vasc.com and click on the “Investor Conferences” icon a few minutes prior to start time to download any necessary software.
About Stifel, Nicolaus & Company
Stifel Financial Corp. (NYSE:SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated; Keefe Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC; and Century Securities Associates, Inc., and in the United Kingdom and Europe through Stifel Nicolaus Europe Limited. More information is available at www.stifel.com.
About Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Genuity Group Inc. offering institutional and corporate clients idea-driven investment banking, merger and acquisition, research, sales and trading services from offices in 10 countries worldwide. More information is available at www.canaccordgenuity.com.
About Vascular Solutions
Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company has launched more than 100 products that are sold to interventional cardiologists, interventional radiologists, electrophysiologists, and vein specialists through its direct U.S. sales force and international independent distributor network.
Contact: Phil Nalbone, VP Vascular Solutions, Inc. (763) 656-4300


San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
OpenAI Addresses Security Vulnerability in macOS App Certification Process
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 



